At SPRIM, we produce and share research, insights, and opinions about the world of healthcare science. This makes us stronger, and helps inform the decisions we make with our partners.

Check out our blog, case studies, and publications to stay ahead of common wisdom.

News & Blog

RegAsk, a Healthcare RegTech Startup, Secures Venture Capital Funding in a Seed Round to Pursue Growth

RegAsk uses artificial intelligence to answer regulatory questions, including inquiries about path-to-market, path-to-claim, product registration and regulatory strategy. … Read More 

Save the Date: TKS 1 Investor Day 2019 in Singapore

We are pleased to announce our TKS 1 Investor Day in Singapore. The event will occur on Friday, January 25, 2019 and will include presentations from our portfolio companies, followed by Q&A sessions. … Read More 

Startups Aim to Fix ‘Broken’ Clinical Trials System

ObvioHealth, meanwhile, has developed an app that enables studies to be run using mobile devices. Data from smart devices such as a Bluetooth blood pressure monitor can integrate with the app, according to the company, which earlier this year raised … Read More 

Case Studies

Fighting Antibiotic-Associated Diarrhea

A high quality probiotic product containing high concentration of Lactobacillus acidophilus and L. casei demonstrated to prevent Clostridium difficile infection and diarrhea during antibiotic treatment. The trial coordinated by SPRIM was published in the American Journal of Gastroenterology. … Read More 

Improving Patient Outcomes In Intensive Care Units through Nutrition Monitoring

A SPRIM initiated partnership: The GE Healthcare and Nestlé Health Science collaboration aims to connect the technology that delivers nutrients to the patient with the advanced analytic technology that measures the specific nutrition a patient needs. … Read More 

Spearheading a Partnership between Two Major Brands to Fight Diabetes

SPRIM spearheaded a public-private partnership between Unilever and Abbott Nutrition and helped create an innovative solution to curb the progression of diabetes in India. A digital platform was created that more than 100,000 people in India used for lifestyle modifications. … Read More 


Comparison of two probiotics A1:H53 follow-on formulae in chinese infants: Bifidobacterium Animalis Subsp.Lactis HN019 protected against respiratory tract infections

Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage

Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia